AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

THC Biomed Intl Ltd.

$0 +$0.00 (+99,900%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0.02
Year Range
$0$0.02
Market Cap
205.01K
AVG Volume
2.56K
Trailing/Forward PE
-1.07/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
2026-09-30
Primary Exchange
Other OTCUS
Revenue (CAD) · TTM
02M4M6M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
THCBF Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
23 Q32.86M
23 Q23.08M
23 Q12.87M
22 Q43.34M
22 Q33.46M
22 Q23.87M
22 Q14.29M
21 Q43.77M
21 Q33.74M
21 Q23.53M
Net Income (CAD) · TTM
-8M-6M-4M-2M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
THCBF Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
23 Q3-3.67M
23 Q2-2.87M
23 Q1-3.42M
22 Q4-3.07M
22 Q3-3.08M
22 Q2-4.27M
22 Q1-5.64M
21 Q4-6.36M
21 Q3-5.58M
21 Q2-4.55M
Operating Income (CAD) · TTM
-6M-4M-2M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
THCBF Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
23 Q3-3.05M
23 Q2-2.94M
23 Q1-3.57M
22 Q4-3.2M
22 Q3-3.23M
22 Q2-3.8M
22 Q1-5.2M
21 Q4-5.94M
21 Q3-5.19M
21 Q2-4.16M
EBITDA (CAD) · TTM
-6M-4M-2M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
THCBF EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
23 Q3-2.03M
23 Q2-1.25M
23 Q1-1.85M
22 Q4-1.48M
22 Q3-1.66M
22 Q2-2.85M
22 Q1-4.24M
21 Q4-4.96M
21 Q3-4.2M
21 Q2-3.15M
Cash Flows (CAD) · TTM
-3M-2M-1M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
THCBF Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
23 Q3-735.61K
23 Q2-1.42M
23 Q1-1.74M
22 Q4-2.25M
22 Q3-1.98M
22 Q2-1.85M
22 Q1-1.54M
21 Q4-1.38M
21 Q3-1.12M
21 Q2-738.21K
EPS (CAD) · TTM
-0.04-0.03-0.02-0.01021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
THCBF EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
23 Q3-0.02
23 Q2-0.02
23 Q1-0.02
22 Q4-0.02
22 Q3-0.02
22 Q2-0.03
22 Q1-0.03
21 Q4-0.04
21 Q3-0.03
21 Q2-0.03
Expenses (CAD) · TTM
01M2M3MR&DSG&ACapex21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
THCBF Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
23 Q31.26M
23 Q21.43M
23 Q11.68M
22 Q41.9M
22 Q31.9M
22 Q22.23M
22 Q12.23M
21 Q42.11M
21 Q32.01M
21 Q22M
Shares Outstanding (CAD) · TTM
-750K-500K-250K0250KBuybacks (Repurchases)Stock-Based Compensation21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
THCBF Shares Outstanding (CAD) · TTM by quarter
PeriodShares Outstanding (CAD) · TTM
23 Q3-43.24K
23 Q2-43.24K
23 Q1-43.24K
22 Q4-137.44K
22 Q3-233.97K
22 Q2-664.4K
22 Q1-730.6K
21 Q4-671.01K
21 Q3-542.96K
21 Q2-33.81K
Free Cash Flow Yield
-400000%-300000%-200000%-100000%0%med -324.09%Jan 25May 25Sep 25Jan 26May 26Sep 26
THCBF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-325.56%
Sep 26-324412.69%
Aug 26-322.78%
Aug 26-326.02%
Aug 26-323.46%
Aug 26-321.99%
Jul 26-320.24%
Jul 26-318.42%
Jul 26-320.06%
Jul 26-317.1%
Jul 26-316.42%
Jun 26-316.27%
Jun 26-317.41%
Jun 26-320799.16%
Jun 26-321.95%
May 26-325.46%
May 26-324.81%
May 26-326.47%
May 26-328.15%
May 26-330.29%
Apr 26-328365.46%
Apr 26-327.8%
Apr 26-324.24%
Apr 26-322.41%
Mar 26-323.05%
Mar 26-327.09%
Mar 26-327.05%
Mar 26-330.93%
Feb 26-329.03%
Feb 26-328.17%
Feb 26-329.61%
Feb 26-328.25%
Jan 26-329.56%
Jan 26-327.61%
Jan 26-322.51%
Jan 26-322.58%
Jan 26-326875.21%
Dec 25-328.23%
Dec 25-325.25%
Dec 25-325.87%
Dec 25-324.82%
Nov 25-321.19%
Nov 25-318.31%
Nov 25-320.09%
Nov 25-319.49%
Oct 25-320.48%
Oct 25-320.68%
Oct 25-320.12%
Oct 25-320.6%
Oct 25-321.8%
Sep 25-321.94%
Sep 25-325.83%
Sep 25-324.14%
Sep 25-324.61%
Aug 25-326.63%
Aug 25-324.68%
Aug 25-324.83%
Aug 25-326.25%
Aug 25-325466.87%
Jul 25-327.6%
Jul 25-327.1%
Jul 25-327.9%
Jul 25-330.38%
Jun 25-328.07%
Jun 25-326.77%
Jun 25-330.48%
Jun 25-327.82%
May 25-326.7%
May 25-326.88%
May 25-321.31%
May 25-322.12%
May 25-324.88%
Apr 25-324.04%
Apr 25-324.4%
Apr 25-323.69%
Apr 25-315.43%
Mar 25-313.54%
Mar 25-312.72%
Mar 25-312.29%
Mar 25-312.45%
Feb 25-310.36%
Feb 25-315.67%
Feb 25-316.47%
Feb 25-314.12%
Jan 25-308.99%
Jan 25-312935.12%
Jan 25-309932.8%
Jan 25-311.27%
Jan 25-310.7%
Dec 24-311.41%
Dec 24-312279.58%
Dec 24-315.39%
Dec 24-317112.78%
Nov 24-320.53%
Nov 24-321.18%
Nov 24-318.62%
Nov 24-322.75%
Nov 24-321.8%
Oct 24-323.1%
Oct 24-13.27%
Price to Sales
00.511.52med 0.08Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
THCBF Price to Sales by quarter
PeriodPrice to Sales
Sep 260.08
Sep 260
Aug 260.08
Aug 260.08
Aug 260.08
Aug 260.08
Jul 260.08
Jul 260.08
Jul 260.08
Jul 260.08
Jul 260.08
Jun 260.08
Jun 260.08
Jun 260
Jun 260.08
May 260.08
May 260.08
May 260.08
May 260.08
May 260.08
Apr 260
Apr 260.08
Apr 260.08
Apr 260.08
Mar 260.08
Mar 260.08
Mar 260.08
Mar 260.08
Feb 260.08
Feb 260.08
Feb 260.08
Feb 260.08
Jan 260.08
Jan 260.08
Jan 260.08
Jan 260.08
Jan 260
Dec 250.08
Dec 250.08
Dec 250.08
Dec 250.08
Nov 250.08
Nov 250.08
Nov 250.08
Nov 250.08
Oct 250.08
Oct 250.08
Oct 250.08
Oct 250.08
Oct 250.08
Sep 250.08
Sep 250.08
Sep 250.08
Sep 250.08
Aug 250.08
Aug 250.08
Aug 250.08
Aug 250.08
Aug 250
Jul 250.08
Jul 250.08
Jul 250.08
Jul 250.08
Jun 250.08
Jun 250.08
Jun 250.08
Jun 250.08
May 250.08
May 250.08
May 250.08
May 250.08
May 250.08
Apr 250.08
Apr 250.08
Apr 250.08
Apr 250.08
Mar 250.08
Mar 250.08
Mar 250.08
Mar 250.08
Feb 250.08
Feb 250.08
Feb 250.08
Feb 250.08
Jan 250.08
Jan 250
Jan 250
Jan 250.08
Jan 250.08
Dec 240.08
Dec 240
Dec 240.08
Dec 240
Nov 240.08
Nov 240.08
Nov 240.08
Nov 240.08
Nov 240.08
Oct 240.08
Oct 241.94
EV/EBITDA
101214161820med 14.52Oct 20Nov 20Nov 20Dec 20Dec 20Jan 21Jan 21
THCBF EV/EBITDA by quarter
PeriodEV/EBITDA
Jan 2119.09
Jan 2115.74
Jan 2117.39
Dec 2014.03
Dec 2014.84
Dec 2015.07
Dec 2013.85
Dec 2014.51
Nov 2014.31
Nov 2011.9
Nov 2014.52
Nov 2015.67
Oct 2014.03
Price/Operating Cashflow
0200400600med 344.62Nov 20Dec 20Jan 21Feb 21Mar 21Apr 21Apr 21
THCBF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Apr 21348.96
Apr 21344.62
Apr 21370.05
Apr 21403.53
Apr 21424.48
Mar 21421.63
Mar 21436.12
Mar 21430.46
Mar 21422.41
Feb 21407.99
Feb 21487.48
Feb 21547.57
Feb 21426.27
Jan 21353.86
Jan 21142.8
Jan 21115.27
Jan 21128.85
Dec 20101.31
Dec 20107.91
Dec 20109.85
Dec 2099.77
Dec 20105.22
Nov 20103.58
Nov 2083.82
Nov 20105.31
Nov 20114.72
Oct 20101.3
Price to Book
00.511.5med 0.05Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
THCBF Price to Book by quarter
PeriodPrice to Book
Sep 260.05
Sep 260
Aug 260.05
Aug 260.05
Aug 260.05
Aug 260.05
Jul 260.05
Jul 260.05
Jul 260.05
Jul 260.05
Jul 260.05
Jun 260.05
Jun 260.05
Jun 260
Jun 260.05
May 260.05
May 260.05
May 260.05
May 260.05
May 260.05
Apr 260
Apr 260.05
Apr 260.05
Apr 260.05
Mar 260.05
Mar 260.05
Mar 260.05
Mar 260.05
Feb 260.05
Feb 260.05
Feb 260.05
Feb 260.05
Jan 260.05
Jan 260.05
Jan 260.05
Jan 260.05
Jan 260
Dec 250.05
Dec 250.05
Dec 250.05
Dec 250.05
Nov 250.05
Nov 250.05
Nov 250.05
Nov 250.05
Oct 250.05
Oct 250.05
Oct 250.05
Oct 250.05
Oct 250.05
Sep 250.05
Sep 250.05
Sep 250.05
Sep 250.05
Aug 250.05
Aug 250.05
Aug 250.05
Aug 250.05
Aug 250
Jul 250.05
Jul 250.05
Jul 250.05
Jul 250.05
Jun 250.05
Jun 250.05
Jun 250.05
Jun 250.05
May 250.05
May 250.05
May 250.05
May 250.05
May 250.05
Apr 250.05
Apr 250.05
Apr 250.05
Apr 250.05
Mar 250.05
Mar 250.05
Mar 250.05
Mar 250.05
Feb 250.05
Feb 250.05
Feb 250.05
Feb 250.05
Jan 250.05
Jan 250
Jan 250
Jan 250.05
Jan 250.05
Dec 240.05
Dec 240
Dec 240.05
Dec 240
Nov 240.05
Nov 240.05
Nov 240.05
Nov 240.05
Nov 240.05
Oct 240.05
Oct 241.18
THC Biomed Intl Ltd.
THCBF
Stockpicker

Video analysis: THCBF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.